ZERIT (E.R. Squibb & Sons, L.L.C.)
Welcome to the PulseAid listing for the ZERIT drug offered from E.R. Squibb & Sons, L.L.C.. This Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | E.R. Squibb & Sons, L.L.C. |
| NON-PROPRIETARY NAME: | Stavudine |
| SUBSTANCE NAME: | STAVUDINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE, GELATIN COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1994-06-24 |
| END MARKETING DATE: | 0000-00-00 |
ZERIT HUMAN PRESCRIPTION DRUG Details:
| Item Description | ZERIT from E.R. Squibb & Sons, L.L.C. |
| LABELER NAME: | E.R. Squibb & Sons, L.L.C. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 15(mg/1) |
| START MARKETING DATE: | 1994-06-24 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0003-1964_c6c7d0ff-a3cb-4a61-8acd-aceaf2b979fd |
| PRODUCT NDC: | 0003-1964 |
| APPLICATION NUMBER: | NDA020412 |
Other STAVUDINE Pharmaceutical Manufacturers / Labelers:
